Position history for BlackRock Finance, Inc.'s holdings in 4D MOLECULAR THERAPEUTICS IN
BlackRock Finance, Inc. holds 4.9M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $102.8M as of 2024-Q2. The position was increased (++14.3% shares). FDMT represents 0.0% of BlackRock Finance, Inc.'s portfolio.
Current Value
$102.8M
Current Shares
4.9M
Total Value Change
$0
Total Shares Change
0
Other major holders of FDMT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, VIKING GLOBAL INVESTORS LP
Upgrade to Pro to see multi-quarter position history and trends. View plans
Increased |
| 4.9M |
+14.3% |
| $102.8M |
| 0.0% |
| $20.99 |
34 |